BioSpace News Archive

Alvotech and STADA are strengthening their existing strategic alliance for high-quality, cost-effective biosimilars by extending their partnership to cover AVT03, a clinical-stage biosimilar candidate referencing the Prolia®/Xgeva® medicines for osteoporosis and cancer-related bone loss respectively.

Bright Peak Therapeutics, a biotechnology company developing next-generation, multifunctional immunotherapies, announced that it raised $90 million in a Series C financing.

Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products and services, is excited to announce the launch of its new PreBioM™ microplate product line for microbiome analysis and organism selection.

Cyrus Biotechnology, Inc., a Seattle-based software-enabled biotechnology firm, is spinning out a software and services group, Levitate Bio, to bring the Cyrus platform to the larger biopharma industry.

Anteris Technologies Ltd announced a summation of the Company’s presentation at the New York Valves annual Conference held at the Jacob K. Javits Convention Center in New York City.

Pharvaris, a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema attacks, announced the annual general meeting of shareholders will take place on Friday, June 28, 2024, at 15:00 CEST.

Athira Pharma, Inc. announced that it has completed the first cohort of healthy volunteers in its ongoing, first-in-human, dose escalation Phase 1 clinical study evaluating ATH-1105, an oral, small molecule positive modulator of the neurotrophic hepatocyte growth factor system in development for the treatment of amyotrophic lateral sclerosis.

Syntis Bio, Inc. announced its launch as a clinical-stage biopharmaceutical company with a mission to develop oral therapies that provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to the world’s most prevalent conditions.

Zimmer Biomet Holdings, Inc., a global medical technology leader, announced a limited distribution agreement with THINK Surgical, Inc. regarding its wireless, handheld, TMINI Miniature Robotic System for total knee arthroplasty.

Cybin Inc., a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, is pleased to announce that Dr. Atul R. Mahableshwarkar M.D., DLFAPA, has joined the Company as Senior Vice President, Clinical Development.